Analytical Data
-
Gene name
SLC39A1
- Application
-
Alternative Names
hZIP1; IRT1; S39A1_HUMAN; SLC39A1; Solute carrier family 39 member 1; Zinc transporter ZIP1; Zinc-iron-regulated transporter-like; ZIP-1; ZIP1; ZIRTL; Zrt- and Irt-like protein 1
-
Species
Human
-
Source
E. coli
-
Tag
N-GST
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9NY26
-
Expression Region
M126-R179
-
Protein Length
Partial
-
Molecular Weight
30-35 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
SLC39A1, a member of the solute carrier (SLC) family, encodes a zinc transporter that plays a crucial role in cellular zinc homeostasis. Zinc is an essential trace element involved in numerous biological processes, including enzymatic reactions, protein synthesis, and gene expression. Abnormalities in zinc transport can lead to various health issues, including immune dysfunction, developmental disorders, and neurodegenerative diseases. Research on SLC39A1 has gained prominence due to its implications in these conditions and its potential role in cancer progression and metastasis. The recombinant protein of SLC39A1 offers a valuable tool for studying its structure-function relationship and understanding the molecular mechanisms of zinc transport. By using recombinant SLC39A1, researchers can investigate the protein's binding affinities, transport kinetics, and regulatory mechanisms. Additionally, characterizing this protein may pave the way for the development of therapeutic strategies targeting zinc dysregulation. Overall, the study of SLC39A1 recombinant protein enhances our understanding of zinc biology and its impact on health and disease.
